ICD code T37.4X2D – Antiviral drug poisoning, intentional self-harm

Key Takeaways

T37.4X2D covers antiviral drug poisoning where intent is intentional self-harm and the visit is a subsequent (follow-up) encounter, not initial active treatment.

The placeholder ‘X’ at position 5 is required by ICD-10-CM structure – omitting it creates an invalid code that payers will reject.

Only the treating provider can document intentional self-harm intent; coders cannot infer it from clinical circumstances or medication lists alone.

Pabau’s claims management software flags missing external cause codes and encounter-qualifier mismatches before submission, reducing T37.4X2D denials at source.

ICD-10 code T37.4X2D at a glance

ICD-10 code T37.4X2D is a valid, billable ICD-10-CM code confirmed in the official tabular list maintained by CMS and the National Center for Health Statistics. The table below summarises the key reference facts coders need before submitting a claim. For a deeper understanding of medical billing fundamentals, Pabau’s guide covers the full revenue cycle from encounter to payment.

What antiviral drug poisoning means: Code definition and drug classes

Antiviral drug poisoning under T37.4 covers any situation where a patient suffers toxic effects from a drug whose primary pharmacological action is antiviral. This is distinct from an adverse effect – the drug itself is the problem, not an idiosyncratic reaction to a correctly administered dose. The T37.4 category applies when the quantity, route, or circumstances of administration fall outside what was prescribed or intended.

The following drug classes fall within the T37.4 scope, per the ICD-10-CM tabular inclusion notes:

• Antiretrovirals: Nucleoside reverse transcriptase inhibitors (NRTIs), protease inhibitors, integrase inhibitors used in HIV treatment
• Antiinfluenza agents: Neuraminidase inhibitors such as oseltamivir, zanamivir, and baloxavir
• Nucleoside analogues: Aciclovir, valaciclovir, ganciclovir, and related agents for herpes virus infections
• Antiprotozoal antivirals: Agents used against protozoan infections with antiviral pharmacology

Not every antimicrobial falls here. Antibiotics, antifungals, and antiparasitic drugs that lack a specifically antiviral mechanism belong in adjacent T-code categories. Misclassifying an antibacterial overdose under T37.4 is a coding error that payers will flag on audit. When the specific drug is documented, verify its pharmacological class before selecting T37.4.

Breaking down ICD-10 code T37.4X2D character by character

Each of the seven characters in T37.4X2D carries a distinct coding meaning. Understanding the structure prevents the most common submission errors – particularly the omitted placeholder X and the misread intent digit.

The placeholder X at position 5 is not optional. ICD-10-CM uses it to hold a character slot open for future expansion of the T37.4 subcategory. Submitting T37.42D (omitting X) produces a six-character code that does not exist in the tabular list, and most clearinghouses will reject the claim before it reaches the payer.

What “subsequent encounter” (7th character D) means in practice

The 7th character D designates a subsequent encounter – a visit that occurs after the patient has received active treatment for the poisoning event and is now receiving routine follow-up care. The treating provider is no longer managing the acute toxic episode; they are monitoring recovery, managing residual symptoms, or adjusting ongoing therapy.

The most common coding error here is using character A for every visit. Active treatment may span multiple visits – for example, repeated ED encounters during a prolonged acute episode all use A. The switch to D happens when the nature of care shifts from managing the toxicity to monitoring recovery. If the notes describe “follow-up for antiviral overdose” or “outpatient check after discharge,” D is almost always correct. If the notes describe titrating antidotes, managing organ toxicity, or stabilising the patient, A applies.

Intentional self-harm antiviral poisoning: What the 6th character “2” requires

Intentional self-harm in ICD-10-CM coding means the patient deliberately took the antiviral drug in a manner intended to cause self-injury, regardless of whether injury resulted. The 6th character 2 sits on the intent axis, alongside three alternatives:

• 1 – Accidental/unintentional: Overdose due to error, misread prescription, or accidental ingestion
• 2 – Intentional self-harm: Deliberate self-poisoning with self-harm or suicidal intent
• 3 – Assault: Administered by another party with intent to harm
• 4 – Undetermined: Intent cannot be established from available documentation

Only the treating provider can document intentional self-harm. A coder cannot infer this from the medication list, the quantity prescribed, or clinical circumstances alone. The medical record must include an explicit statement from the physician, nurse practitioner, or other licensed provider that the ingestion was intentional. Psychiatric consult notes, crisis assessment documentation, and discharge summaries are all valid sources – but coders must not assign character 2 without that provider statement in the chart. Facilities following behavioral health documentation workflows typically have standardised fields for documenting self-harm intent, which reduces ambiguity at the point of coding.

Poisoning vs. adverse effect vs. underdosing: Choosing the right T37.4 code

Three distinct clinical situations can arise when a patient is harmed in connection with an antiviral drug, and ICD-10-CM codes each one differently. Using the wrong category is one of the most common errors on ICD-10-CM audit reviews.

For adverse effects, the manifestation code – the actual symptom or organ damage – is sequenced first, with T37.4X5_ as a secondary code. For poisoning (including T37.4X2D), the T-code is sequenced first, followed by the manifestation and the external cause code.

Related codes: T37.4X2D within the T37.4 family

T37.4X2D belongs to a structured family of codes that share the antiviral-poisoning root. Each sibling code changes one axis – encounter type or intent – while keeping the drug category fixed. Coders working on complex poisoning cases often need to select across this family depending on which visit is being coded.

External cause codes required with T37.4X2D

ICD-10-CM guidelines strongly recommend, and many payers contractually require, external cause codes alongside T37.4X2D. These secondary codes document the circumstances surrounding the poisoning event – where it occurred, what the patient was doing, and their social context at the time. Per the CDC ICD-10-CM tabular list, external cause codes are always sequenced after the principal diagnosis.

For intentional self-harm poisoning, the most relevant external cause block is X60-X84 (intentional self-harm). The specific code from this range identifies the substance or mechanism. Alongside this, coders should consider:

• Place of occurrence (Y93._): Where the event happened – home, hospital, residential institution
• Activity code (Y99.8): What the patient was doing at the time, if documented
• External cause status (Y99.8): Civilian, military, or recreational context

External cause reporting requirements vary by payer and setting. Hospital inpatient coders are typically held to higher external cause reporting standards than outpatient providers. When in doubt, include them – omitting an expected external cause code is a leading cause of T37.4X2D claim denials. Pabau’s electronic claims via Claim.MD clearinghouse integration validates external cause code presence before transmission, catching omissions before they reach the payer.

Documentation requirements for T37.4X2D

A clean T37.4X2D claim depends on the medical record containing five specific documentation elements. Payer audits for intentional self-harm codes focus almost exclusively on intent documentation – it is the element most often missing or unclear when claims are reopened.

• Specific antiviral drug named: The record must identify the actual drug (e.g. “aciclovir”, “oseltamivir”, “tenofovir”) – a generic reference to “antiviral medication” creates coding ambiguity and may not survive audit
• Intent documented by the treating provider: An explicit provider statement that the ingestion was intentional self-harm; crisis assessment tools, psychiatric consult notes, or discharge summaries all qualify – coders cannot supply this independently
• Encounter type confirmed as follow-up: The notes must reflect that active toxic management has concluded and the visit is for monitoring or ongoing care
• Psychiatric or toxicology consult notes: Where obtained, these reinforce the intent documentation and are frequently requested by payers auditing self-harm codes
• Linkage to the original poisoning event: The record should reference the initial encounter or the original event date so the subsequent-encounter designation is clinically coherent

Facilities with medical billing compliance protocols for behavioral health encounters typically embed these documentation checkpoints into their intake and discharge workflows, reducing post-submission audit exposure. Using structured digital forms that require a provider attestation of intent at discharge is the most reliable way to ensure the chart supports character 2 coding.

Common claim denials for T37.4X2D and how to avoid them

T37.4X2D carries a higher denial risk than most diagnostic codes because it combines a sensitive clinical category (intentional self-harm) with two technical coding requirements (encounter qualifier and external cause reporting) that must all align. Effective denial management workflows for this code address five root causes.

• Missing or mismatched external cause code: Many payers require an X60-X84 self-harm external cause code alongside T37.4X2D. If the external cause code is absent or reflects a different intent (e.g. accidental), expect a medical necessity denial. Resolution: Implement a pre-submission edit rule that flags T37.4X2_ codes submitted without an X60-X84 companion.
• Intent not supported by documentation: Payer auditors request the medical record and find no provider statement confirming intentional self-harm. Resolution: Add a provider attestation field to discharge documentation for all self-harm cases; ensure psychiatric consult notes are attached to the claim file.
• Wrong encounter qualifier (A instead of D): Using 7th character A for a routine follow-up visit signals that active treatment is ongoing, which may trigger a request for admission records. Resolution: Code A only while toxicity management is active; switch to D at the first post-discharge visit.
• Missing CPT companion codes: Some payers expect psychiatric evaluation or crisis counseling CPT codes (e.g. 90832, 90837, or 90839) alongside intentional self-harm ICD-10 codes. Submitting T37.4X2D as a standalone diagnosis without any behavioral health procedure code raises a clinical coherence flag. Resolution: Confirm the encounter includes a qualifying mental health service before submission.
• Outdated code version: Submitting a code that was valid in a prior fiscal year but has been revised or superseded generates an invalid code rejection. Resolution: Validate T37.4X2D against the CMS ICD-10-CM annual update files for the specific date of service before billing. Submitting claims through medical claims management software that maintains current code catalogs eliminates this risk automatically.

Reduce T37.4X2D denials before they happen

Pabau’s Claim.MD integration validates external cause codes, encounter qualifiers, and companion CPT requirements before every submission – so intentional self-harm claims reach the payer complete the first time.

Book a demo

ICD-9-CM crosswalk: Converting T37.4X2D to legacy codes

Workers’ compensation carriers, some legacy billing systems, and retrospective research datasets may still require ICD-9-CM codes. The GEMs (General Equivalence Mappings) provide an approximate forward/backward translation, but no exact one-to-one equivalent exists for T37.4X2D. The mappings below are approximate per the ICD-10-CM/ICD-9 crosswalk databases.

GEMs mappings are inherently approximate because ICD-9-CM lacked the granular intent and encounter-type axes that ICD-10-CM introduced. When converting for research or legacy purposes, note that 965.8 covers a broader drug category than antiviral-specific poisoning. For payers or auditors requiring a specific antiviral drug reference, supplemental documentation is advisable when submitting legacy codes.

Conclusion

T37.4X2D is a technically straightforward code that becomes a denial risk when any one of its three axes – drug class, intent, or encounter type – is under-documented or miscoded. The intent qualifier (character 2) requires an explicit provider statement; the encounter qualifier (character D) requires confirmed completion of active treatment; and the external cause companion codes require a systematic pre-submission check.

Pabau’s integration with Claim.MD validates code combinations, flags missing companion codes, and maintains current-year ICD-10-CM catalogs so T37.4X2D claims arrive at the payer complete and correct. To see how Pabau handles intentional self-harm coding workflows from documentation through submission, book a demo.

Continue your research

Need a denial management framework for complex diagnosis codes? Denial management in healthcare covers root-cause analysis, appeal workflows, and prevention strategies for high-risk ICD-10 submissions.

Submitting claims through a clearinghouse for the first time? Pabau’s Claim.MD clearinghouse guide explains how the integration validates codes, routes claims to 4,000+ US payers, and handles electronic remittance advice.

Looking for ICD-10 coding guidance across the full billing cycle? What is revenue cycle management maps every step from patient registration and diagnosis coding through payment posting and denial resolution.

Frequently Asked Questions